The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of biotechs, backed by investors, are taking a disease-centric approach to extending the human lifespan.
Longevity Biotechs Strive for Better Aging—Not Just Life Extension Read More »
The restraining order prevents the Trump administration from enacting a provision of the massive tax and policy law that would cut Medicaid funding for Planned Parenthood.
Judge temporarily blocks megabill’s Planned Parenthood Medicaid funding ban Read More »
The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.
Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small study met safety and performance goals.
Implantable glucose monitor competitor emerges with early data Read More »
A federal judge ordered the government to reinstate critical documents as soon as possible, but left the door open for the Trump administration to take a second crack at removing the data.
Court orders HHS to restore webpages related to ‘gender ideology’ Read More »
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible for treatment with the Farapulse pulsed field ablation system.
Boston Scientific gets expanded PFA label for persistent AFib Read More »
BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the approval of its cell therapy NurOwn, whose BLA was withdrawn in 2023. A Phase IIIb trial was scheduled to begin last month.
The deal marks an end for CAR T company Cargo Therapeutics, which has been slashing its workforce and cutting programs since the January decision to halt its lead candidate for a certain type of aggressive large B cell lymphoma.
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout Read More »
Unos científicos han descubierto un modo de idear nuevas técnicas con las que administrar fármacos proteicos en la piel o a través de la piel. Concretamente, se trata de técnicas basadas en proteínas recombinantes capaces de modular la permeabilidad de tejid …
President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the biopharma industry. The new tax law also cuts Medicaid funding, posing a minimal risk to pharma’s bottomlines and potentially jeopardizing hospitals’ 340B status. It does not,
